Table 2.
Demographic and clinical characteristics of the Intermountain Healthcare patients with asthma in 2017.
| Characteristics | Data instances related to no asthma hospital visit in the subsequent year (n=18,444), n (%) | Data instances related to asthma hospital visits in the subsequent year (n=812), n (%) | Data instances (n=19,256), n (%) | |
| Gender | ||||
|
|
Female | 11,001 (59.65) | 439 (54.06) | 11,440 (59.41) |
|
|
Male | 7443 (40.35) | 373 (45.94) | 7816 (40.59) |
| Age (years) | ||||
|
|
≥65 | 3833 (20.78) | 46 (5.67) | 3879 (20.14) |
|
|
18 to 65 | 9879 (53.56) | 386 (47.54) | 10,265 (53.31) |
|
|
6 to <18 | 3054 (16.56) | 181 (22.29) | 3235 (16.80) |
|
|
<6 | 1678 (9.10) | 199 (24.51) | 1877 (9.75) |
| Ethnicity | ||||
|
|
Non-Hispanic | 16,242 (88.06) | 618 (76.11) | 16,860 (87.56) |
|
|
Hispanic | 2020 (10.95) | 192 (23.65) | 2212 (11.49) |
|
|
Unknown or not reported | 182 (0.99) | 2 (0.25) | 184 (0.96) |
| Race | ||||
|
|
White | 17,025 (92.31) | 681 (83.87) | 17,706 (91.95) |
|
|
Native Hawaiian or other Pacific Islander | 299 (1.62) | 47 (5.79) | 346 (1.80) |
|
|
Black or African American | 361 (1.96) | 42 (5.17) | 403 (2.09) |
|
|
Asian | 195 (1.06) | 10 (1.23) | 205 (1.06) |
|
|
American Indian or Alaska Native | 146 (0.79) | 13 (1.60) | 159 (0.83) |
|
|
Unknown or not reported | 418 (2.27) | 19 (2.34) | 437 (2.27) |
| Duration of asthma (years) | ||||
|
|
>3 | 7734 (41.93) | 389 (47.91) | 8123 (42.18) |
|
|
≤3 | 10,710 (58.07) | 423 (52.09) | 11,133 (57.82) |
| Insurance | ||||
|
|
Self-paid or charity | 1136 (6.16) | 142 (17.49) | 1278 (6.64) |
|
|
Public | 4920 (26.68) | 208 (25.62) | 5128 (26.63) |
|
|
Private | 12,388 (67.17) | 462 (56.90) | 12,850 (66.73) |
| Smoking status | ||||
|
|
Never smoker or unknown | 13,956 (75.67) | 583 (71.80) | 14,539 (75.50) |
|
|
Former smoker | 2243 (12.16) | 83 (10.22) | 2326 (12.08) |
|
|
Current smoker | 2245 (12.17) | 146 (17.98) | 2391 (12.42) |
| Comorbidity | ||||
|
|
Sleep apnea | 2925 (15.86) | 78 (9.61) | 3003 (15.60) |
|
|
Sinusitis | 746 (4.04) | 34 (4.19) | 780 (4.05) |
|
|
Premature birth | 435 (2.36) | 41 (5.05) | 476 (2.47) |
|
|
Obesity | 3389 (18.37) | 116 (14.29) | 3505 (18.20) |
|
|
Gastroesophageal reflux | 3477 (18.85) | 71 (8.74) | 3548 (18.43) |
|
|
Eczema | 273 (1.48) | 34 (4.19) | 307 (1.59) |
|
|
Cystic fibrosis | 94 (0.51) | 1 (0.12) | 95 (0.49) |
|
|
Chronic obstructive pulmonary disease | 1033 (5.60) | 23 (2.83) | 1056 (5.48) |
|
|
Bronchopulmonary dysplasia | 12 (0.07) | 3 (0.37) | 15 (0.08) |
|
|
Anxiety or depression | 3815 (20.68) | 131 (16.13) | 3946 (20.49) |
|
|
Allergic rhinitis | 382 (2.07) | 10 (1.23) | 392 (2.04) |
| Asthma medication prescription | ||||
|
|
Systemic corticosteroid | 11,327 (61.41) | 693 (85.34) | 12,020 (62.42) |
|
|
Short-acting, inhaled beta-2 agonist | 13,046 (70.73) | 739 (91.01) | 13,785 (71.59) |
|
|
Mast cell stabilizer | 8 (0.04) | 0 (0.00) | 8 (0.04) |
|
|
Long-acting beta-2 agonist | 47 (0.25) | 5 (0.62) | 52 (0.27) |
|
|
Leukotriene modifier | 3364 (18.24) | 209 (25.74) | 3573 (18.56) |
|
|
Inhaled corticosteroid/long-acting beta-2 agonist combination | 4178 (22.65) | 222 (27.34) | 4400 (22.85) |
|
|
Inhaled corticosteroid | 6817 (36.96) | 424 (52.22) | 7241 (37.60) |